Abstract
Soft tissue deformation(STD) causes the most prominent source of error in skin marker (SM) based motion analysis, commonly referred to as Soft Tissue Artifact (STA). To compensate for its effect and to accurately assess in vivo joint kinematics, quantification of STD in three-dimension (3D) is essential. In the literature, different invasive and radiological approaches have been employed to study how STA propagates in joint kinematics. However, there is limited reference data extensively reporting distribution of the artifact itself in 3D.
The current study was thus aimed at quantifying STD in 10 subjects along three anatomical directions. Biplanar X-ray system was used to determine true bone and SM positions while the subjects underwent quasi-static single leg flexion.
STD exhibited inter-subject similarity. A non-uniform distribution was observed at the pelvis, thigh and shank displaying maximum at the thigh (up to 18.5 mm) and minimum at the shank (up to 8 mm). STD at the pelvis and thigh displayed inter-marker similarity. STD at the pelvis was found direction independent, showing similar distribution in all the 3 directions. However, the thigh and shank exhibited higher STD in the proximal-distal direction of the bone embedded anatomical reference frame. These findings may provide more insights while interpreting motion analysis data as well to effectively strategize STA compensation methods.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
ParisTech BiomecAM chair program
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Comite de Protection des Personnes (CPP NX06036)
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data can be provided subject to request
